Pharmafile - Research and Development News
Evonetix has announced the opening of its early access programme for semiconductor synthesised DNA. The company’s DNA synthesis capability brings...
AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone, has been...
Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could increase the number of the...
Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient...
Research, published by Nature Communications, has revealed how the structural brain abnormalities found in a variety of brain disorders is affected...
A February to May 2022 Medscape survey of 1,012 UK doctors revealed that 45% of junior doctors are considering leaving the profession, citing a...
Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of...
Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress into a Phase III...
PCI has announced a significant expansion of its facility in Tredegar, Wales, UK, designed to help keep up to date with the market growth of powerful...
Micronesia's first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific Island nation.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
